INS and metabolic dysfunction-associated steatotic liver disease: GLP-1 receptor signaling in hepatocytes revealed that exenatide alleviates hepatic steatosis by regulating hepatic insulin clearance through induction in mice, highlighting the fact that increased insulin clearance has been linked to the improvement of NAFLD [87].